| Sponsored by Immunogenomics 2015
HudsonAlpha Institute presents Immunogenomics 2015! An international conference that brings together leaders and researchers exploring the application of genomics technologies to understand the immune system and development of disease. September 29 – 30, 2015 Huntsville, Alabama, USA http://hudsonalpha.org/immunogenomicsconference/ |
|
 |
Science
Weekly News
|
|
|
|
|
|
| A roundup of the week’s top stories in Science:
|
|
| In Brief |
|
In science news around the world, a report criticizes the World Health Organization’s response to the Ebola epidemic, the European Commission appoints three scouts to seek new science advisers, the Oklahoma Supreme Court clears the way for earthquake lawsuits in the state, the U.S. Fish and Wildlife Commission considers the fate of the red wolf in the wild, and more. Also, leadership changes are in the works at the University Corporation for Atmospheric Research in Boulder, Colorado; at the Woods Hole Oceanographic Institution; and at the National Academy of Sciences. And researchers learn why the vivid yellow paint used in masterpieces by Henri Matisse and Vincent van Gogh has faded.
|
|
| In Depth |
|
Europe
Erik Stokstad
Greek scientists are in an even greater state of uncertainty about the future of research in their debt-ridden country. On 5 July, Greek voters rejected the terms of a bailout package proposed by European Union negotiators, but what this decision means for the country’s place in Europe is still unclear. The scientific community fears a Greek departure from Europe’s common currency, the euro, or even the European Union itself. The latter would imperil E.U. funds that Greek science relies on. Early this week, there was still hope for a new deal, and Greece’s vice minister for research and innovation has said that even if Greece leaves the euro, there is no reason to believe that Greece would have to leave the European Union and forgo its research funds. But a return to the drachma would increase the cost of supplies and equipment ordered from abroad and could also worsen the brain drain from Greece.
Climate Change
Cally Carswell
As the climate changes, plants and animals are on the move. So far, many are redistributing in a similar pattern: As habitat that was once too cold warms up, species are expanding their ranges toward the poles, while boundaries closer to the equator have remained more static. Bumblebees, however, appear to be a disturbing exception, according to a new study in Science. A comprehensive look at dozens of species, it finds that many North American and European bumblebees are failing to “track” warming by colonizing new habitat north of their historic range. Simultaneously, they are disappearing from the southern portions of their range. “Climate change is crushing (bumblebee) species in a vice,” says ecologist Jeremy Kerr of the University of Ottawa in Canada, the study’s lead author. Where bumblebees vanish, the wild plants and crops they pollinate could also suffer.
Women in Science
Dennis Normile
Japan’s female scientists have been making agonizingly slow progress in academia. Only 22.5% of all full-time faculty positions at the nation’s universities were held by women in 2014, a rate far below that in other advanced countries. And the percentage is even lower at Japan’s major research universities. To increase the participation of women in the academic workforce, the government has set numerical targets for recruiting for academic positions in two successive 5-year basic plans for science and technology adopted since 2006. However, targets were dropped from the draft of the next 5-year plan. The omission has sparked a debate over what is holding women back and the most effective way to boost their participation in academia. A number of advocates for women are calling for targets to be included in the final version of the plan, which will be completed by the end of this year and take effect next April.
Biomedicine
Ken Garber
A drug, tetrathiomolybdate (TM), which mops up copper in the body and that had already failed in a series of previous cancer clinical trials, is getting a second chance. A phase II trial of the drug in women who had been successfully treated for breast cancer but have a high risk of recurrence suggests that it can prevent the growth of new tumors. Yet the promise of this copper depletion strategy appears tarnished—not by clinical results but by corporate strategy. The oncologist who led the phase II trial now wants to proceed with a larger, phase III trial of TM. But the rights to treating cancer with TM are held by a Swedish biotech company that is developing the drug instead for Wilson disease, a rare inherited disease of copper accumulation. The company, Wilson Therapeutics, has no immediate plans to test TM in cancer patients, its CEO acknowledges, and for now will not sublicense the drug.
Ken Garber
Dozens of human enzymes incorporate or utilize copper, taking advantage of the metal’s readiness to donate or accept electrons to catalyze key bio chemical reactions. Tumors, however, may be especially dependent on the metal. Copper, for example, promotes angiogenesis, the growth of blood vessels that can feed an expanding tumor, and depleting it may keep cancer in check. Copper also binds an enzyme that enables tumor cells to metastasize and is required for signaling by the mutant BRAF protein, which drives half of melanomas and many other cancers. “Maybe what we’ll find is that particular cancer types are more susceptible to particular copper-dependent processes,” says pharmacologist Donita Brady of Duke University in Durham, North Carolina.
Planetary Science
Eric Hand
A remarkable half-century of planetary reconnaissance will end on 14 July, when the New Horizons spacecraft swoops past Pluto. The flyby comes 50 years to the day after Mariner 4 flew past Mars and returned the first image from another planet. Stamatios “Tom” Krimigis, the former head of the space department at Johns Hopkins University’s Applied Physics Laboratory in Laurel, Maryland, had a hand in both missions, as well as in visits to all the other worlds in the solar system. An expert in planetary magnetospheres, Krimigis has seen it all. But he is not yet done: His instrument on Voyager 1 is now plumbing interstellar space, and he is planning on being a part of Solar Probe Plus, a spacecraft that will visit the sun’s corona.
Science Policy
Kelly Servick
The United States is preparing to modernize the rules that govern inventions in agricultural biotechnology, according to a White House memo released last week. The multiyear review process will clarify the roles of the agencies that determine the safety of genetically altered plants and animals: the Food and Drug Administration, the U.S. Department of Agriculture, and the Environmental Protection Agency. The current framework—last updated in 1992—didn’t anticipate precise gene-editing methods, such as CRISPR, which some argue don’t require the same review as traditional genetic engineering. Meanwhile, new techniques for genetic modification have sidestepped the approval process under the current framework, and many hope the White House initiative will clarify exactly what products need regulating.
|
|
| Feature |
|
Warren Cornwall
Scientists are reviving an old and largely discarded idea for disposing of the United States’ most radioactive nuclear waste: sticking it down holes drilled 5 kilometers into Earth’s crust. The renewed interest in deep boreholes comes as the federal government struggles to find a way to rid itself of more than 83,000 metric tons of spent nuclear fuel and remnants of nuclear weapons production. The Obama administration has abandoned the previous plan to bury it in a mine in Nevada’s Yucca Mountain, amid opposition from Nevada politicians. Now, scientists at Sandia National Laboratories are moving ahead with an $80 million dollar, 5-year test of deep boreholes, to see if they are practical and safe. Some advocates suggest boreholes could be a solution for disposing of most high-level waste. But others warn that the technology is untested, or would only work for a small portion of the waste that’s small enough to easily fit down a borehole. One prime candidate is highly radioactive cesium and strontium now stored in slender steel canisters at an aging building at the U.S. Department of Energy’s Hanford Site in Washington state.
Warren Cornwall
As the U.S. government struggles to find a place to put the nation’s hottest nuclear waste, one region has emerged as an eager suitor. In the flat, desert country along the border between Texas and New Mexico, two groups are pursuing competing plans to store some of the 70,000 metric tons of spent fuel rods now housed at 75 spots around the country. A third company is prospecting for a potential site in the area as well. The region is increasingly familiar with the business of nuclear material. Already, it hosts the government’s only site opened for buying lower level radioactive waste, a uranium enrichment factory, and the country’s largest private nuclear waste disposal site. The new interest is welcomed by policymakers in the Obama administration. They are trying to set a new course for disposing of the country’s nuclear waste, after abandoning plans to put much of it in Nevada’s Yucca Mountain. The U.S. Energy Department now hopes to find a place to store spent fuel rods for decades. At the same time, it’s preparing to recruit communities willing to host sites for permanently burying either commercial spent fuel or waste left from building nuclear bombs.
|
|
|
|
|
| Sponsored by Immunogenomics 2015
HudsonAlpha Institute presents Immunogenomics 2015! An international conference that brings together leaders and researchers exploring the application of genomics technologies to understand the immune system and development of disease. September 29 – 30, 2015 Huntsville, Alabama, USA http://hudsonalpha.org/immunogenomicsconference/ |
|
|
|